HomeSKYE • NASDAQ
add
Skye Bioscience Inc
Previous close
$1.51
Day range
$1.50 - $1.61
Year range
$1.14 - $5.96
Market cap
46.95M USD
Avg Volume
1.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.24M | 117.05% |
Net income | -17.62M | -123.02% |
Net profit margin | — | — |
Earnings per share | -0.45 | -123.35% |
EBITDA | -18.06M | -115.58% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 48.59M | -34.45% |
Total assets | 52.16M | -40.22% |
Total liabilities | 8.48M | -41.30% |
Total equity | 43.68M | — |
Shares outstanding | 30.99M | — |
Price to book | 1.07 | — |
Return on assets | -78.00% | — |
Return on capital | -87.96% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -17.62M | -123.02% |
Cash from operations | -10.75M | -51.49% |
Cash from investing | -11.86M | -36,418.58% |
Cash from financing | 18.16K | 100.87% |
Net change in cash | -22.58M | -144.88% |
Free cash flow | -4.39M | 37.02% |
About
Founded
2011
Website
Employees
16
